COGT fund manager activity
Cogent Biosciences, Inc · Nasdaq. Reported by 2 tracked fund managers in their 13F filings, Q3 2022 to Q2 2026.
Q4 2025
| Manager | Activity | Shares | Value | % of portfolio | Filed |
|---|---|---|---|---|---|
| Stanley Druckenmiller - Duquesne Family Office | Added | 2,214,470 | $78,658,000 | 1.86% | Feb 17, 2026 |
| Ken Fisher - Fisher Asset Management | Trimmed | 47,914 | $1,701,905 | 0.00% | Feb 9, 2026 |
Q3 2025
| Manager | Activity | Shares | Value | % of portfolio | Filed |
|---|---|---|---|---|---|
| Stanley Druckenmiller - Duquesne Family Office | New | 1,059,580 | $15,216,000 | 0.39% | Nov 14, 2025 |
| Ken Fisher - Fisher Asset Management | Trimmed | 103,492 | $1,486,145 | 0.00% | Nov 12, 2025 |